Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Equity of Non-controlling Interest
Total
Stockholders' equity, Beginning balance at Feb. 01, 2020 $ 82 $ 452,833 $ (434,221)   $ 18,694
Common Stock, Shares, Outstanding period beginning at Feb. 01, 2020 8,208,227        
Net loss     (6,828)   (6,828)
Common stock issuances pursuant to equity compensation awards, Value $ 1 (3)     (2)
Common stock issuances pursuant to equity compensation awards, Shares 32,652        
Share-based payment compensation   615     615
Common stock and warrant issuance, Value $ 7 1,418     1,425
Common stock and warrant issuance, Shares 731,937        
Stockholders' equity, ending balance at May. 02, 2020 $ 90 454,863 (441,049)   13,904
Common Stock, Shares, Outstanding period end at May. 02, 2020 8,972,816        
Net loss     1,054   1,054
Common stock issuances pursuant to equity compensation awards, Value $ 1 (6)     (5)
Common stock issuances pursuant to equity compensation awards, Shares 64,456        
Share-based payment compensation   108     108
Common stock and warrant issuance, Value $ 10 2,375     2,385
Common stock and warrant issuance, Shares 1,104,377        
Stockholders' equity, ending balance at Aug. 01, 2020 $ 101 457,340 (439,995)   17,446
Common Stock, Shares, Outstanding period end at Aug. 01, 2020 10,141,649        
Stockholders' equity, Beginning balance at Jan. 30, 2021 $ 130 474,375 (447,455)   $ 27,050
Common Stock, Shares, Outstanding period beginning at Jan. 30, 2021 13,019,061       13,019,061
Net loss     (3,228) $ (150) $ (3,378)
Common stock issuances pursuant to equity compensation awards, Value $ 1 (262)     (261)
Common stock issuances pursuant to equity compensation awards, Shares 76,341        
Share-based payment compensation   668     668
Common stock and warrant issuance, Value $ 33 21,191     21,224
Common stock and warrant issuance, Shares 3,289,000        
Investment of non-controlling interest       3,430 3,430
Stockholders' equity, ending balance at May. 01, 2021 $ 164 495,972 (450,683) 3,280 48,733
Common Stock, Shares, Outstanding period end at May. 01, 2021 16,384,402        
Stockholders' equity, Beginning balance at Jan. 30, 2021 $ 130 474,375 (447,455)   $ 27,050
Common Stock, Shares, Outstanding period beginning at Jan. 30, 2021 13,019,061       13,019,061
Stockholders' equity, ending balance at Jul. 31, 2021 $ 212 536,835 (454,932) 3,148 $ 85,263
Common Stock, Shares, Outstanding period end at Jul. 31, 2021 21,254,414       21,254,414
Stockholders' equity, Beginning balance at May. 01, 2021 $ 164 495,972 (450,683) 3,280 $ 48,733
Common Stock, Shares, Outstanding period beginning at May. 01, 2021 16,384,402        
Net loss     (4,249) (132) (4,381)
Common stock issuances pursuant to equity compensation awards, Shares 39,094        
Share-based payment compensation   768     768
Common stock and warrant issuance, Value $ 48 40,095     40,144
Common stock and warrant issuance, Shares 4,830,918        
Stockholders' equity, ending balance at Jul. 31, 2021 $ 212 $ 536,835 $ (454,932) $ 3,148 $ 85,263
Common Stock, Shares, Outstanding period end at Jul. 31, 2021 21,254,414       21,254,414